Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Technology-assisted early mobilization for ICU patients on ventilators

Official title: The Effect of Technology-Assisted Early Mobilization Program Among Patients in the Intensive Care Units: A Randomized Controlled Trial

Run by Taipei Medical University · NCT06700694 · Data updated 2026-11-12

This trial will test whether a technology-assisted, family-engaged early mobilization program helps critically ill adults on ventilators avoid ICU-acquired weakness.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment138 (estimated)
SponsorTaipei Medical University
Academic / other
Locations1 site (Taipei)
StatusRecruiting
StartedMarch 4, 2025
Main results expectedFebruary 2027
Study endsApril 2027
Registry record updatedMarch 9, 2026
Trial IDNCT06700694 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who have been mechanically ventilated at least 24 hours, have RASS between 0 and -1, can communicate in Chinese, have no major sensory or movement restrictions, and are expected to remain in the ICU more than 96 hours are ideal candidates.

Probably not a fit

Patients with preexisting severe brain or spinal injury, neuromuscular disease, delirium at enrollment, very high early APACHE II scores (>25), or those unable to follow commands or with anticipated short ICU stays are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-blind, three-arm randomized trial will enroll 138 critically ill adults and randomize them 1:1:1 to a technology-assisted early mobilization group, a systematic protocol-oriented early mobilization group, or usual care. Interventions start within 72 hours of ventilator use and the technology-assisted arm adds in-bed activities supported primarily by family members alongside physiotherapist-led protocolized mobilization. The systematic early mobilization arm receives the same protocolized mobilization without the technology/family component, while the control arm receives routine rehabilitation. The primary outcome is occurrence of ICU-acquired weakness, with secondary outcomes including muscle strength, delirium, sleep status, and other clinical outcomes.

Why it matters

Potential benefit: If successful, the program could reduce ICU-acquired weakness and improve muscle strength and recovery after critical illness.

How similar studies have gone: Prior studies of early mobilization in the ICU have shown benefits for reducing weakness and improving outcomes, but technology-assisted, family-delivered in-bed programs remain relatively novel with limited direct evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged ≥ 18 years
* Being mechanically ventilated ≥ 24 hours
* Richmond Agitation-Sedation Scale (RASS): 0 to -1
* No vision, hearing, or body movements restriction
* With clear consciousness and ability to communicate in Chinese
* Expected to stay in the ICU \> 96 hours.

Exclusion Criteria:

* Have developed delirium before enrollment (ICDSC \> 4)
* With acute physiology and chronic health evaluation (APACHE II) score \> 25 after ICU admission within 24 hours
* With muscle weakness caused by severe acute brain injury (e.g., traumatic brain injury or stroke), spinal coral injury, other neuromuscular conduction diseases, or long-term bedridden or hemiplegia.

Where it's running

  • Taipei Medical University Hospital
    Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.